首页|热毒宁注射液联合硫酸特布他林治疗AECOPD患者的效果

热毒宁注射液联合硫酸特布他林治疗AECOPD患者的效果

扫码查看
目的:探讨热毒宁注射液联合硫酸特布他林治疗慢性阻塞性肺疾病急性加重(AECOPD)患者的效果.方法:回顾性分析2022 年 2 月至 2023 年 8 月该院收治的 122 例AECOPD患者的临床资料,根据治疗方案不同将其分为对照组和观察组各 61 例.在常规治疗基础上,对照组采用硫酸特布他林雾化吸入治疗,观察组在对照组基础上联合热毒宁注射液治疗.治疗 7 d后,比较两组临床疗效,治疗前后肺功能[慢性阻塞性肺疾病评估测试(CAT)]评分、运动耐量[6 min步行距离(6MWD)]、肺通气功能指标[第 1 秒用力呼气容积(FEV1)、用力肺活量(FVC)、FEV1/FVC、呼气流速峰值(PEF)]水平、血清炎性指标[白细胞介素-6(IL-6)、C反应蛋白(CRP)、缺氧诱导因子-1α(HIF-1α)、微小RNA-146a(miR-146a)]水平,以及不良反应发生率.结果:观察组治疗总有效率为96.72%(59/61),高于对照组的 85.25%(52/61),差异有统计学意义(P<0.05);治疗后,观察组CAT评分及血清IL-6、CRP、HIF-1α水平均低于对照组,6MWD值大于对照组,FEV1、FVC、FEV1/FVC、PEF、miR-146a水平均高于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:热毒宁注射液联合硫酸特布他林治疗AECOPD患者效果良好,可提高肺功能和运动耐量,加快症状缓解,减轻炎症反应,效果优于单用硫酸特布他林.
Effects of Reduning injection combined with Terbutaline sulfate in treatment of AECOPD
Objective:To investigate effects of Reduning injection combined with Terbutaline sulfate in treatment of acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods:The clinical data of 122 patients with AECOPD admitted to this hospital from February 2022 to August 2023 were retrospectively analyzed.According to different treatment options,they were divided into control group and observation group,61 cases each.On the basis of conventional symptomatic treatment,the control group was treated with Terbutaline sulfate aerosol inhalation,while the observation group was treated with Reduning injection on the basis of that of the control group.After 7 days of treatment,the clinical efficacy,the pulmonary function[chronic obstructive pulmonary disease assessment test(CAT)]score,the exercise tolerance[6 min walking distance(6MWD)],the pulmonary ventilation function indexes[forced expiratory volume in one second(FEV1),forced vital capacity(FVC),FEV1/FVC,peak expiratory flow rate(PEF)]levels,the serum inflammatory indexes[interleukin-6(IL-6),C-reactive protein(CRP),hypoxia inducible factor-1α(HIF-1α),microRNA-146a(miR-146a)]levels,and the incidence of adverse reactions were compared between the two groups before and after the treatment.Results:The total effective rate of the observation group was 96.72%(59/61),which was higher than 85.25%(52/61)of the control group,and the difference was statistically significant(P<0.05).After the treatment,the CAT score and the serum levels of IL-6,CRP and HIF-1α in the observation group were lower than those in the control group,the 6MWD value was higher than that in the control group,the levels of FEV1,FVC,FEV1/FVC,PEF and miR-146a were higher than those in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Reduning injection combined with Terbutaline sulfate is effective in the treatment of the AECOPD patients,which can improve the lung function and the exercise tolerance,accelerate the symptom relief and reduce the inflammatory response.Moreover,it is superior to single Terbutaline sulfate treatment.

Reduning injectionTerbutalineChronic obstructive pulmonary diseaseAcute exacerbationHypoxia inducible factor-1αMicroRNA

孙涛

展开 >

周口市中心医院重症医学科,河南 周口 466000

热毒宁注射液 特布他林 慢性阻塞性肺疾病 急性加重 缺氧诱导因子-1α 微小RNA

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(3)
  • 15